19th Conference of the International Society of Geriatric Oncology

Integrative oncology – Leaving no one behind / GENEVA Switzerland 14-16 Nov 2019

November 16, 2019 / Saturday

07:00 - 08:30

Geriatric Evaluation Workshop
Separate registration is required for this workshop due to limited capacity.

Chairs: Cindy Kenis (BE) (NAH), Kah Poh (Melissa) Loh (US) (Young SIOG)

Case Introduction

Work on the Below Stations:
1) Geriatric screening tools (VES-13, Geriatric 8), Gábor Liposits (DK), Carolina Uranga (US)
2) Cognitive assessments (MOCA, MMSE, Mini-Cog), Allison Magnuson (US), Martine Puts (CA)
3) Physical Performance Batteries (SPPB, TUG, gait speed, etc.), Mackenzi Pergolotti (US), Schroder Sattar (CA)
4) Chemotherapy toxicity calculators (CARG, CRASH, MAX2), Nicolò Matteo Luca Battisti (GB), Sukeshi Arora (US)
5) Life expectancy calculators, Enrique Soto Perez de Celis (MX), Nina Rosa Neuendorff (DE)
6) Social support and psychological health, Kristen Haase (CA), Fábio Gomes (GB)
7) Medications and polypharmacy, Erika Ramsdale (US), Ginah Nightingale (US)

Wrap Up

08:30 - 09:30

Lung Cancer MDT
Chair: Ishwaria Subbiah (US)

Case 1: Stage IIIa lung cancer
Case 2a: Metastatic disease with good PS
Case 2b: Metastatic disease with poor PS
Panelists: Michael T. Jaklitsch (US), Holly Holmes (US), Lore Decoster (BE), Fábio Gomes (GB), Noam Vanderwalde (US)

09:30 - 10:30

Short Oral Abstract Presentations
Chairs: William Dale (US), Nina Rosa Neuendorff (DE)

Functional capacity and levels of physical activity as risk factors for hospitalization in elderly cancer patients: prospective cohort, Jurema T O L Sales (BR)
O17 Functional recovery in older women undergoing surgery for gynaecological malignancies: a systematic review and narrative synthesis, Fionna E Martin (GB)
O18 Fatigue is independently associated with functional status limitations in older adults with cancer – results from the cancer and aging resilience evaluation (CARE) registry, Grant R Williams (US)
O19 Decline in physical function (PF) is associated with pretreatment depressive symptoms, decreased mobility, more pain, and dyspnea in older cancer patients referred for systemic cancer treatment, Magnus Harneshaug (NO)
O20 Stepping on: Cancer edition changes behaviors and improves balance in older adults with cancer and their caregivers, Tanya M Wildes (US)
O21 Risk factors for falls in older persons with cancer: a multicenter study, Jessie De Cock (BE)
O22 The high impact of preoperative social frailty on overall survival in elderly gastrointestinal cancer patients, Rei Ono (JP)
O23 Implementation of a clinical frailty pathway at a cancer centre – a quality improvement project, Fábio Gomes (GB)
Geriatric and oncological predictors of survival and chemotherapy toxicities in elderly patients with metastatic non small cell lung cancer: an analysis of ESOGIA trial, Florence Canouï Poitrine (FR)
O25 Cancer-specific mortality and competing causes of death in older adults: a prospective multicenter cohort study (ELCAPA 19), Deborah Assouan (FR)
O26 Depressive symptom profiles and survival in older patients with cancer: latent class analysis of the ELCAPA cohort study, Florence Canouï Poitrine (FR)
O27 Discussing older patients during oncological multidisciplinary team meetings; is there a difference compared to younger patients? Suzanne Festen (NL)
O28 Patient-defined preferences and health outcome prioritization among older adults with cancer starting chemotherapy, Enrique Soto Perez De Celis (MX)
O29 “I have a doctor that handles all the other stuff.” Perceptions of older adults about discussing age-related conditions with their oncologists: A university of Rochester NCI community oncology research program (NCORP) geriatric assessment (GA) trial, Sindhuja Kadambi (US)
O30 Guided geriatric interventions (GI) in older adults with cancer: What, how, and for whom? The French PACA EST Cohort Experience, Rabia Boulahssass (FR)

10:30 - 11:00  Poster Viewing & Coffee Break
11:00 - 12:00

Hematology MDT
Chair: Vicki Morrison (US)

Case 1: AML
Case 2: Non Hodgkins Lymphoma
Panelists: Kah Poh (Melissa) Loh (MY & US), Heidi Klepin (US), Reinhard Stauder (AT), Konstantinos Christofyllakis (DE), Raul Cordoba (ES), Noam Vanderwalde (US)

12:00 - 13:00

Keynote Oral Abstract Presentations
Chairs: Siri Rostoft (NO), William P. Tew (US)

Patient Reported Outcomes Measures (PROMs) in geriatric patients undergoing major surgery for solid cancer. 90-day preliminary report on 643 patients from the Geriatric Oncology Surgical Assessment and Functional rEcovery after Surgery (GOSAFE) study, Isacco Montroni (IT)
KO2 Optimizing chemotherapy for frail and/ or elderly patients with advanced gastroesophageal cancer (aGOAC): The GO2 phase III trial, Daniel Edmund Bryan Swinson (GB)
KO3 Predicting life expectancy in older adults with advanced cancer: An evaluation of oncologists’ estimates and a geriatric assessment-based predictive model, Jennifer L Lund (US)
KO4 Prognostic value of inflammation-based routine biomarkers in older patients with cancer: pooled analysis of three prospective cohorts, Nadia Oubaya (FR)
KO5 Cost effectiveness of a geriatric oncology clinic, Zuhair Alam (CA)

13:00- 14:30  Break for Lunch
14:30 - 15:30

Prostate Cancer MDT
Chair: Cecilia Lund (DK)

Case 1: Localised prostate cancer
Case 2: Metastatic prostate cancer
Panelists: Lucinda Morris (AU), Antonella Brunello (IT), Cecilia Lund (DK), Patrice Jichlinski (CH)

15:30 - 16:30

Presidential Session
Chairs: Hans Wildiers, President (BE), Ravindran Kanesvaran, President-Elect (SG)

Presidential Address, Hans Wildiers (BE)
SIOG CEO Address, Najia Musolino (CH)
SIOG 2019 Paul Calabresi Award Presentation, Marije Hamaker (NL)
SIOG 2019 Awards:

SIOG 2019 Nursing & Allied Health Investigator Award
SIOG 2019 Young Investigator Award
SIOG 2019 Best Poster Award
SIOG 2020

16:30 - 17:00  Poster Viewing & Coffee Break
17:00 - 18:30

Debate Session: Controversial Issues in Geriatric Oncology
Chairs: Martine Extermann (US), Kwok-Leung Cheung(GB), Enrique Soto Perez de Celis (MX)

Debate 1:
Can chemotherapy toxicity calculators be used across diseases and settings?
Discussing arguments: 
FOR: Allison Magnuson (US)
AGAINST: Erin Moth (AU)

Debate 2: Should breast and colorectal cancer screening be carried out in older adults?
Discussing arguments:
FOR: Lodovico Balducci (US)
AGAINST: Shabbir Alibhai (CA)